ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag products survey funding

The Human Genome
Arielle Emmett | Jul 23, 2000 | 10+ min read
Life sciences took center stage virtually around the world June 26. President Bill Clinton, flanked on the left by Celera Genomics Group president J. Craig Venter and on the right by National Human Genome Research Institute director Francis S. Collins, announced the completion of "the first survey of the entire human genome."
Notebook
The Scientist Staff | Jul 7, 1996 | 7 min read
On June 14, a House Appropriations subcommittee gave some researchers cause for celebration when it surprisingly voted to remove a provision in a government spending bill that extended a ban on federal funding of human embryo research. However, their glee was short-lived. The full panel turned around on June 25 and adopted an amendment to continue the research ban. John Eppig, senior staff scientist at Jackson Laboratory in Bar Harbor, Maine, doubts that the ban will be overturned anytime soon,
Democratic Presidential Contenders Have Little To Say On The Subject Of Research
Jeffrey Mervis | Feb 2, 1992 | 10+ min read
While the five hopefuls have opinions on such matters as education and science funding, their views lack depth WASHINGTON--The five major Democratic contenders for president of the United States generally agree that the country needs to strengthen its technology base, that spending on civilian research should be increased, and that universities remain the key to the nation's scientific preeminence. At the same time, they differ over whether it makes sense to build the superconducting supercol
An Array of Options
Kate Yandell | Jun 1, 2015 | 9 min read
A guide for how and when to transition from the microarray to RNA-seq
National Research Council Proposes an Academic Patent Shield
Ted Agres | Jul 4, 2004 | 4 min read
Arti RaiCourtesy of Duke Law SchoolThe decades of freedom from liability for patent infringement may be over for US universities and research institutes, unless the National Research Council (NRC) gets its way. In the past, universities could use patented techniques and devices without a license, because of the so-called experimental use exemption. In other words, patents could be infringed in academic pursuits.Action in the federal courts has closed that loophole. Instead of letting universitie
When Science Has a Potential Payoff
Karen Pallarito(kpallarito@the-scientist.com) | Jan 16, 2005 | 8 min read
In a recent three-hour session at a Chicago hotel room, the University of Wisconsin's technology transfer office hammered out the final details of licensing deal that granted Durham, NC-based Inspire Pharmaceuticals the right to use several patents to develop glau coma treatments.
Stepping Up Mouse Sequencing
Eugene Russo | Nov 12, 2000 | 4 min read
At a featured symposium of last month's American Society of Human Genetics (ASHG) meeting in Philadelphia, Bob Waterston, director of the genome sequencing center at Washington University in St. Louis, reviewed how and why the Human Genome Project (HGP) accelerated in 1998. Having at that point generated a disappointing 10 percent of the total human sequence, sequencing centers had to greatly scale up efforts in order to reach this past summer's milestone "draft" ahead of schedule. First, said W
Fighting the 10/90 Gap
Ricki Lewis | May 12, 2002 | 5 min read
While wealthy nations pursue drugs to treat baldness and obesity, depression in dogs, and erectile dysfunction, elsewhere millions are sick or dying from preventable or treatable infectious and parasitic diseases.1 It's called the 10/90 gap. "Less than 10% of the worldwide expenditure on health research and development is devoted to the major health problems of 90% of the population," explains Els Torreele, co-chair of a working group that provided background recently for an initiative announced
Intelligent Redesign
Ishani Ganguli | Aug 1, 2006 | 7 min read
FEATURELab Design   Main image: © Getty ImagesSmaller images: Justin MacNochie Photography/SmithgroupWith billions being spent on new labs and renovations, do shinier labs really make for better science? BY ISHANI GANGULIARTICLE EXTRASRelated Articles:Lab Rehab Redesign and the Bottom Line It's Easy Going GreenAnatomy of an energy-sustainable lab renovationWeb Extra:Lab Rehab: Laying out other options
Prospecting for Gold in Genome Gulch
Amy Adams | Apr 14, 2002 | 9 min read
The human genome is much like the American West of the 1850s: Everyone wants a piece of the pie. Similar to gold prospectors of 150 years ago, biotech and pharmaceutical companies, and even universities, are frantically searching for the nuggets of gold that will help them find the mother lode—a gene whose function is sufficiently marketable to make all of the preliminary research worthwhile. Companies that do strike gold get to introduce new classes of drugs to the market. Others hope to

Run a Search

ADVERTISEMENT